Exploring India's Generic Pharmacy Model and Its Global Impact through Jan Aushadhi Kendras
Adoption of Jan Aushadhi Kendras
More than 10 countries are looking to imbibe India's generic pharmacy model to make affordable medicines accessible to the public, according to reports. Mauritius became the first country to launch the International Janaushadhi Kendra, enabling it to source about 250 high-quality medicines from the Pharmaceuticals and Medical Devices Bureau of India.
Global Interest in Affordable Medicines
- Nepal, Sri Lanka, Bhutan, Ghana, Suriname, Nicaragua, Mozambique, the Solomon Islands, and Taliban-ruled Afghanistan are already considering opening Jan Aushadhi Kendras.
- Countries like Burkina Faso, Fiji Islands, and Saint Kitts and Nevis are in talks to replicate this scheme.
The Pradhan Mantri Bharatiya Janaushadhi Pariyojana (PMBJP), launched in November 2008, aims to provide quality medicines at affordable prices through Jan Aushadhi Kendras. From 80 Kendras in 2014 to 13,822 by September 2024, these centers mark a significant improvement in healthcare access. In September, record sales of Rs 200 crore were achieved, showcasing the success of this initiative.
Impact on Healthcare Costs
Medicines at these Kendras are priced 50% to 90% lower than branded alternatives, significantly reducing the financial burden on patients. The Union government aims to establish 25,000 more Kendras by March 2026, further enhancing accessibility to affordable healthcare.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.